Table 1.
Clinical, genetic, and pathological heterogeneity in FTD
| Clinical subtypes | Genetic mutations | Pathological subtypes |
|---|---|---|
| • Behavioral variant FTD | • TAU (coding for the microtubule associated protein tau) | • Pick’s disease |
| • Non-fluent primary progressive aphasia | • PRGN (coding for progranulin) | • Tau-positive FTDP-17 |
| • semantic dementia | • VCP (coding for the valosin-containing protein) | • TDP-43 positive FTD with or without motor neuron disease |
| • FTD with Parkinsonism | • CHMP2B (coding for the charged multivesicular protein 2B) | • FUS positive |
| • FTD with motor neuron disease | • TDP (coding for the tar-DNA binding protein 43) | • Progressive supranuclear palsy |
| • FTD with inclusion body myopathy and Paget’s disease of the bone | • FUS (coding for the fused in sarcoma protein) | • Corticobasal degeneration |
| • Progressive supranuclear palsy | • Unidentified gene on chromosome 9 | • Ubiquitin-positive (tau/TDP43/FUS-negative) FTD |
| • Corticobasal degeneration |